Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Netanely

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 8, 2026
The Oocyte/Antral Follicle Count Index: Does Maximizing Oocyte Yield Translate into Better Assisted Reproductive Technology Outcomes?Shir Danieli-Gruber, Onit Sapir, Dan Netanely, et al.
Therapeutic Advances in Hematology|August 11, 2021
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective studyRoy Vitkon, Dan Netanely, Shai Levi, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 8, 2026
The Oocyte/Antral Follicle Count Index: Does Maximizing Oocyte Yield Translate into Better Assisted Reproductive Technology Outcomes?Shir Danieli-Gruber, Onit Sapir, Dan Netanely, et al.
Therapeutic Advances in Hematology|August 11, 2021
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective studyRoy Vitkon, Dan Netanely, Shai Levi, et al.
Pageof 1